Sunovion Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration approved the New Drug Application for Lonhala Magnair (glycopyrrolate) Inhalation Solution (25 mcg twice daily) – also known as SUN-101/eFlow – for the long-term, maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema.
Genentech, a member of the Roche Group, announced that the U.S. FDA granted full approval for Avastin (bevacizumab) for the treatment of adults with glioblastoma that progressed following prior therapy (referred to as recurrent disease).
With the focus shifting away from the end reporting, companies have continued to invest in systems and processes that manage “upstream” relationships with healthcare providers and consultants, recognizing that the greater compliance risks center around these relationships than on the reported spend itself.
The right balance of data and insights creates a more satisfying monthly campaign report.
Executives from 2017 Manny Award winners/finalists and other healthcare communications agencies participated in this Q&A forum of industry topics.
For the tenth year, Med Ad News chose new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.
Marketers continue to leverage the power of mobile devices, but have learned it’s not all about the apps.
Med Ad News asked the healthcare agency roundtable panel from the magazine’s December 2017 cover story the following question: How is your organization effectively implementing the point-of-care channel to advance health and healthcare outcomes? What are some of the emerging trends in POC communications?
Point of care interactions between patients and healthcare professionals are undergoing significant changes. Whether in the doctor’s office, hospital or pharmacy, new care models are being established that are designed to bring fundamental change to the doctor-patient relationship.
The Coalition for Healthcare Communication (Coalition) has faced multiple challenges in Washington over the years, including major tax legislation (more on that below), and now its Executive Committee has adopted a new mission statement designed to both combat information quackery and its more modern rendition – fake medical news – and to highlight and raise the ethical standards of the medical communication industry.
